Refinement of an open-microcavity optical biosensor for bacterial endotoxin test.

Area of Science:

• Biotechnology
• Biosensing Technology
• Biomedical Engineering

Background:

• The Limulus Amebocyte Lysate (LAL) test is crucial for detecting bacterial endotoxins in pharmaceuticals and vaccines.
• Endotoxins pose significant health risks, including organ dysfunction and mortality.
• Existing LAL assays face limitations in sensitivity and assay duration.

Purpose of the Study:

• To develop an improved Limulus Amebocyte Lysate (LAL) assay for bacterial endotoxin detection.
• To enhance test sensitivity and reduce assay time compared to current industry standards.
• To explore the application of photonic-crystal biosensors in endotoxin quantification.

Main Methods:

• Utilized an open-microcavity photonic-crystal biosensor for endotoxin quantification.
• Employed the Limulus Amebocyte Lysate (LAL) reagent in the novel assay format.
• Quantified endotoxin concentrations using the developed biosensor system.

Main Results:

• Achieved a 10-fold increase in sensitivity for endotoxin detection compared to commercial methods.
• Reduced the assay time by more than 50%.
• Demonstrated the potential for reduced LAL reagent consumption (as low as 5 μL per test).

Conclusions:

• The photonic-crystal biosensor approach significantly enhances bacterial endotoxin testing.
• This novel method offers improved sensitivity, reduced assay time, and cost-effectiveness.
• The technology contributes to more efficient and sustainable endotoxin detection, conserving horseshoe crab resources.